Concert Pharmaceuticals Reports First Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Concert Pharmaceuticals Reports First Quarter 2022 Financial Results

Concert Pharma (CNCE) Misses Q1 EPS by 12c

May 5, 2022 7:29 AM EDT

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($1.03), $0.12 worse than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

... More